Morgan Stanley’s InflaRx IFRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.05M | Buy |
1,175,576
+114,342
| +11% | +$108K | ﹤0.01% | 5121 |
|
|
2025
Q4 | $1.07M | Buy |
1,061,234
+434,635
| +69% | +$540K | ﹤0.01% | 5153 |
|
|
2025
Q3 | $840K | Sell |
626,599
-67,255
| -10% | -$71.4K | ﹤0.01% | 5250 |
|
|
2025
Q2 | $548K | Sell |
693,854
-567,798
| -45% | -$672K | ﹤0.01% | 5424 |
|
|
2025
Q1 | $1.29M | Sell |
1,261,652
-776,514
| -38% | -$1.46M | ﹤0.01% | 4884 |
|
|
2024
Q4 | $5.03M | Buy |
2,038,166
+1,370,035
| +205% | +$2.63M | ﹤0.01% | 3993 |
|
|
2024
Q3 | $1.02M | Sell |
668,131
-159,700
| -19% | -$243K | ﹤0.01% | 5027 |
|
|
2024
Q2 | $1.44M | Sell |
827,831
-150,690
| -15% | -$221K | ﹤0.01% | 4766 |
|
|
2024
Q1 | $1.51M | Sell |
978,521
-867,121
| -47% | -$1.42M | ﹤0.01% | 4734 |
|
|
2023
Q4 | $3.01M | Buy |
1,845,642
+1,211,522
| +191% | +$2.08M | ﹤0.01% | 4716 |
|
|
2023
Q3 | $1.89M | Buy |
634,120
+4,200
| +0.7% | +$16K | ﹤0.01% | 4426 |
|
|
2023
Q2 | $2.81M | Sell |
629,920
-15,112
| -2% | -$67.7K | ﹤0.01% | 4198 |
|
|
2023
Q1 | $1.25M | Sell |
645,032
-3,600
| -0.6% | -$7.77K | ﹤0.01% | 4732 |
|
|
2022
Q4 | $2.01M | Sell |
648,632
-46,745
| -7% | -$119K | ﹤0.01% | 4462 |
|
|
2022
Q3 | $1.84M | Sell |
695,377
-73,355
| -10% | -$165K | ﹤0.01% | 4501 |
|
|
2022
Q2 | $1.11M | Buy |
768,732
+12,700
| +2% | +$19.3K | ﹤0.01% | 4948 |
|
|
2022
Q1 | $1.38M | Sell |
756,032
-117,629
| -13% | -$366K | ﹤0.01% | 4766 |
|
|
2021
Q4 | $4.16M | Buy |
873,661
+150,686
| +21% | +$606K | ﹤0.01% | 3904 |
|
|
2021
Q3 | $1.87M | Sell |
722,975
-28,318
| -4% | -$74.6K | ﹤0.01% | 4624 |
|
|
2021
Q2 | $2.23M | Buy |
751,293
+30,316
| +4% | +$101K | ﹤0.01% | 4542 |
|
|
2021
Q1 | $2.81M | Buy |
720,977
+14,835
| +2% | +$76K | ﹤0.01% | 3986 |
|
|
2020
Q4 | $3.55M | Buy |
706,142
+93,080
| +15% | +$419K | ﹤0.01% | 3633 |
|
|
2020
Q3 | $2.61M | Buy |
613,062
+238,838
| +64% | +$1.1M | ﹤0.01% | 3417 |
|
|
2020
Q2 | $1.72M | Buy |
374,224
+268,407
| +254% | +$1.74M | ﹤0.01% | 3734 |
|
|
2020
Q1 | $404K | Sell |
105,817
-796,564
| -88% | -$2.95M | ﹤0.01% | 4502 |
|
|
2019
Q4 | $3.57M | Sell |
902,381
-119,338
| -12% | -$349K | ﹤0.01% | 3551 |
|
|
2019
Q3 | $2.52M | Buy |
1,021,719
+684,472
| +203% | +$1.99M | ﹤0.01% | 3572 |
|
|
2019
Q2 | $1.07M | Buy |
337,247
+276,424
| +454% | +$8.75M | ﹤0.01% | 4182 |
|
|
2019
Q1 | $2.3M | Buy |
60,823
+30,961
| +104% | +$1.15M | ﹤0.01% | 3470 |
|
|
2018
Q4 | $1.09M | Sell |
29,862
-18,893
| -39% | -$582K | ﹤0.01% | 4212 |
|
|
2018
Q3 | $1.67M | Sell |
48,755
-90
| -0.2% | -$2.9K | ﹤0.01% | 4150 |
|
|
2018
Q2 | $1.57M | Buy |
+48,845
| New | +$1.69M | ﹤0.01% | 4287 |
|
|
2018
Q1 | – | Sell |
-900
| Closed | -$19K | – | 6646 |
|
|
2017
Q4 | $19K | Buy |
+900
| New | +$16.2K | ﹤0.01% | 6090 |
|
Other funds holding IFRX
SCM
6CM
EP
TC
DA
Morgan Stanley's IFRX Position: Q1 2026 in Review
Morgan Stanley increased its InflaRx (IFRX) stake by 11% in Q1 2026, buying an estimated $108K and bringing the position to 1,175,576 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #5121.
Morgan Stanley first reported a position in IFRX in Q4 2017 and has held it in 33 quarters since. The position peaked at $5.03M in Q4 2024. 35 funds tracked by Wall St. Rank hold IFRX as of Q1 2026.
- Morgan Stanley held 1,175,576 shares of InflaRx worth $1.05M as of Q1 2026.
- Morgan Stanley bought 114,342 InflaRx shares in Q1 2026, an estimated $108K.
- InflaRx made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #5121 holding.
- Morgan Stanley first reported a position in InflaRx in Q4 2017 and has held it in 33 quarters since.
- Morgan Stanley's InflaRx position peaked at $5.03M in Q4 2024.
- 35 funds tracked by Wall St. Rank held InflaRx as of Q1 2026.
Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.